Jinhe Biotechnology Co (SZSE:002688) Cash And Cash Equivalents : ¥660 Mil (As of Mar. 2024)

View and export this data going back to 2012. Start your Free Trial

What is Jinhe Biotechnology Co Cash And Cash Equivalents?

Jinhe Biotechnology Co's quarterly cash and cash equivalents declined from Sep. 2023 (¥683.20 Mil) to Dec. 2023 (¥608.13 Mil) but then increased from Dec. 2023 (¥608.13 Mil) to Mar. 2024 (¥660.22 Mil).

Jinhe Biotechnology Co's annual cash and cash equivalents declined from Dec. 2021 (¥517.66 Mil) to Dec. 2022 (¥491.37 Mil) but then increased from Dec. 2022 (¥491.37 Mil) to Dec. 2023 (¥608.13 Mil).

Jinhe Biotechnology Co Cash And Cash Equivalents Historical Data

The historical data trend for Jinhe Biotechnology Co's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jinhe Biotechnology Co Cash And Cash Equivalents Chart

Jinhe Biotechnology Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash And Cash Equivalents

Get a 7-Day Free Trial

361.91

314.80

517.66

491.37

608.13

Jinhe Biotechnology Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Cash And Cash Equivalents	Get a 7-Day Free Trial															421.42	584.37	683.20	608.13	660.22

Jinhe Biotechnology Co Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Jinhe Biotechnology Co (SZSE:002688) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

Jinhe Biotechnology Co Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Jinhe Biotechnology Co's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

Jinhe Biotechnology Co (SZSE:002688) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jinhe Biotechnology Co Ltd (SZSE:002688) » Definitions » Cash And Cash Equivalents

Traded in Other Exchanges

N/A

Address

Zone B3 Xinghai Plaza, 1-7-2 Building 27, Shahekou District, Dalian, CHN, 116023

Website

http://www.jinhe.com.cn

Jinhe Biotechnology Co Ltd is engaged in manufacturing veterinary feed additives, veterinary vaccines, veterinary chemicals, corn starch processing and industrial wastewater treatment business.

Executives

Wang Zhi Jun	Directors, executives
Liu Ying Chun	Executives
Deng Yi Xin	Secretary Dong
Li Fu Zhong	Director
Liu Yun Tian	Directors, executives
Xie Chang Xian	Directors, executives
Wang Dong Xiao	Director
Yao Jian Xiong	Supervisors
Zheng Liu Ji	Supervisors
Niu You Shan	Executives
Wu Ming Xia	Director
Li Wei Qi	Directors, executives
Wu Rui Gang	Executives

Jinhe Biotechnology Co (SZSE:002688) Headlines

No Headlines